Simon Read

Simon Read is currently an Entrepreneur In Residence at Atlas Venture. He is also the Founder and CEO of Curie Therapeutics. Simon has served on the Board of Directors for TRIANA Biomedicines and the Scientific Advisory Board for Q32 Bio Inc.

Simon Read worked as Chief Scientific Officer at Ra Pharmaceuticals from 2016 to 2020. Prior to that, he was Vice President and Head of Innovative Medicines at Grünenthal from 2011 to 2016.